KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Veon (VEON) Intangibles (2016 - 2025)

Veon has reported Intangibles over the past 16 years, most recently at $1.5 billion for Q4 2025.

  • For Q4 2025, Intangibles rose 2.58% year-over-year to $1.5 billion; the TTM value through Dec 2025 reached $1.5 billion, up 2.58%, while the annual FY2025 figure was $1.5 billion, 2.58% up from the prior year.
  • Intangibles was $1.5 billion for Q4 2025 at Veon, roughly flat from $1.6 billion in the prior quarter.
  • Across five years, Intangibles topped out at $4.2 billion in Q2 2021 and bottomed at $386.0 million in Q4 2023.
  • The 5-year median for Intangibles is $1.6 billion (2023), against an average of $2.2 billion.
  • Year-over-year, Intangibles soared 2696.55% in 2021 and then tumbled 58.88% in 2022.
  • Over 5 years, Intangibles stood at $3.2 billion in 2021, then plummeted by 58.88% to $1.3 billion in 2022, then grew by 21.36% to $1.6 billion in 2023, then dropped by 6.73% to $1.5 billion in 2024, then rose by 2.58% to $1.5 billion in 2025.
  • The last three reported values for Intangibles were $1.5 billion (Q4 2025), $1.6 billion (Q2 2025), and $1.5 billion (Q4 2024) per Business Quant data.